Cargando…

Prevalence and prognostic value of atrial fibrillation in patients with cardiac sarcoidosis

AIMS: The prognostic value of the presence of atrial fibrillation (AF) in patients at the time of cardiac sarcoidosis (CS) diagnosis is unknown. This study aimed to investigate the association between AF at the time of CS diagnosis and patient prognosis. METHODS AND RESULTS: This study is a post-hoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujimoto, Yudai, Matsue, Yuya, Maeda, Daichi, Dotare, Taishi, Sunayama, Tsutomu, Iso, Takashi, Nakamura, Yutaka, Singh, Yu Suresvar, Akama, Yuka, Yoshioka, Kenji, Kitai, Takeshi, Naruse, Yoshihisa, Taniguchi, Tatsunori, Tanaka, Hidekazu, Okumura, Takahiro, Baba, Yuichi, Nabeta, Takeru, Minamino, Tohru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578462/ https://www.ncbi.nlm.nih.gov/pubmed/37849788 http://dx.doi.org/10.1093/ehjopen/oead100

Ejemplares similares

The Prognostic Value of B‐Type Natriuretic Peptide in Patients With Cardiac Sarcoidosis Without Heart Failure: Insights From ILLUMINATE‐CS
por: Miyakuni, Shota, et al.
Publicado: (2022)

Prognostic Implication of the Resolution of Myocardial FDG Uptake in Patients With Cardiac Sarcoidosis
por: Okabe, Toshitaka, et al.
Publicado: (2023)

Effectiveness of methotrexate as a second-line treatment for cardiac sarcoidosis assessed via (18)F-FDG PET: a case report
por: Dotare, Taishi, et al.
Publicado: (2022)

Urinary liver‐type fatty acid‐binding protein as a prognostic marker in patients with acute heart failure
por: Sunayama, Tsutomu, et al.
Publicado: (2021)

Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction
por: Ito, Miyuki, et al.
Publicado: (2022)

Prognostic value of postural hypotension in hospitalized patients with heart failure
por: Sunayama, Tsutomu, et al.
Publicado: (2022)

Inaccurate recognition of own comorbidities is associated with poor prognosis in elderly patients with heart failure
por: Maeda, Daichi, et al.
Publicado: (2022)

Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF
por: Saito, Hiroshi, et al.
Publicado: (2022)

Daprodustat for anaemia in patients with heart failure and chronic kidney disease: A randomized controlled study
por: Iso, Takashi, et al.
Publicado: (2022)

Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure
por: Maeda, Daichi, et al.
Publicado: (2021)

Larissa Heart Failure Risk Score and Mode of Death in Acute Heart Failure: Insights from REALITY-AHF
por: Xanthopoulos, Andrew, et al.
Publicado: (2023)

Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure
por: Yoshioka, Kenji, et al.
Publicado: (2022)

Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients
por: Kitakata, Hiroki, et al.
Publicado: (2021)

Validation of telemedicine-based self-assessment of vital signs for patients with COVID-19: A pilot study
por: Kagiyama, Nobuyuki, et al.
Publicado: (2021)

Clinical valuables related to resolution of complete or advanced atrioventricular block after steroid therapy in patients with cardiac sarcoidosis
por: Nabeta, Takeru, et al.
Publicado: (2021)

Impact of body mass index on the outcome of Japanese patients with cardiovascular diseases and/or risk factors hospitalized with COVID-19 infection
por: Saito, Takafumi, et al.
Publicado: (2022)

Sex Differences in Clinical Outcomes Among Patients With COVID-19 and Cardiovascular Disease　― Insights From the CLAVIS-COVID Registry ―
por: Matsumoto, Shingo, et al.
Publicado: (2022)

Effect of the COVID-19 Pandemic on Acute Respiratory Care of Hypoxemic Patients With Acute Heart Failure in Japan　― A Cross-Sectional Study ―
por: Matsue, Yuya, et al.
Publicado: (2020)

Endomyocardial Biopsy for the Diagnosis of Transthyretin Cardiac Amyloidosis in the Era of Multimodality Imaging
por: Sunayama, Tsutomu, et al.
Publicado: (2021)

Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors
por: Higaki, Akinori, et al.
Publicado: (2022)

Impact of brain natriuretic peptide reduction on the worsening renal function in patients with acute heart failure
por: Yoshioka, Kenji, et al.
Publicado: (2020)

Kaplan–Meier survival analysis and Cox regression analyses regarding right ventricular septal pacing: Data from Japanese pacemaker cohort
por: Mizukami, Akira, et al.
Publicado: (2016)

External validation of the 4C Mortality Score for patients with COVID-19 and pre-existing cardiovascular diseases/risk factors
por: Kuroda, Shunsuke, et al.
Publicado: (2021)

(18)F-FDG-PET of cardiac sarcoidosis with subcutaneous nodules
por: Sillanmäki, Saara, et al.
Publicado: (2023)

Hepatocellular carcinoma associated with sarcoidosis
por: Arai, Takuma, et al.
Publicado: (2014)

9‐Year Trend in the Management of Acute Heart Failure in Japan: A Report From the National Consortium of Acute Heart Failure Registries
por: Shiraishi, Yasuyuki, et al.
Publicado: (2018)

Tolvaptan Add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction (DR-AHF): Design and Rationale
por: Minh, Nhat Giang, et al.
Publicado: (2022)

Response to letter to the editor entitled “Association between left atrial sphericity index and clinical outcomes in patients with systolic heart failure”
por: Yazaki, Mayu, et al.
Publicado: (2021)

Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry()
por: Shibahashi, Eiji, et al.
Publicado: (2022)

An Irreversible Worsening Cardiac Function after Withdrawing Medical Treatments in a Patient with Dilated Cardiomyopathy: A Pathological Analysis
por: Yazaki, Mayu, et al.
Publicado: (2020)

Impact of serum lactate dehydrogenase on the short-term prognosis of COVID-19 with pre-existing cardiovascular diseases
por: Masumoto, Akiko, et al.
Publicado: (2022)

Diagnosis of isolated cardiac sarcoidosis based on new guidelines
por: Kawai, Hideki, et al.
Publicado: (2020)

Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors　― Insights From a Nationwide Japanese Cohort Study ―
por: Yoshida, Naofumi, et al.
Publicado: (2021)

Detection of cardiac involvement in pulmonary sarcoidosis using high‐resolution Holter electrocardiogram
por: Maru, Yujin, et al.
Publicado: (2021)

Impact of early treatment with intravenous vasodilators and blood pressure reduction in acute heart failure
por: Kitai, Takeshi, et al.
Publicado: (2018)

Effect of carperitide on the 1 year prognosis of patients with acute decompensated heart failure
por: Nogi, Kazutaka, et al.
Publicado: (2022)

The time-to-treatment concept in acute heart failure: Lessons and implications from REALITY-AHF
por: Kagiyama, Nobuyuki, et al.
Publicado: (2018)

Severe rhabdomyolysis and SARS-CoV-2 vaccination: a reply to the letter by Dr. Josef Finsterer.: Reply to Letter to the Editor regarding our report to Dr. Finsterer.
por: Kamura, Yuya, et al.
Publicado: (2022)

Sarcoidosis
por: Nunes, Hilario, et al.
Publicado: (2007)

Delayed retropharyngeal hematoma following a minor facial blunt trauma
por: Kitai, Yuya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kg02q381fg8scb89uc12kfldce